PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA.\', \'Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.\', \'Department of Surgery, Duke University, Durham, NC 27710, USA.\', \'Infectious Disease Pathogenesis Section, Comparative Medicine Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.\', \'Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA.\', \'Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA; Department of Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA.\', \'Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Center for Applied Genomics and Precision Medicine, Duke University Medical Center, Durham, NC 27710, USA.\', \'Center for Applied Genomics and Precision Medicine, Duke University Medical Center, Durham, NC 27710, USA.\', \'Ragon Institute of MGH, MIT and Harvard, Cambridge, MA 02139, USA; Department of Microbiology, Harvard Medical School, Boston, MA 02115, USA.\', \'Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD 20892, USA.\', \'Vaccine Research Center, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD 20892, USA; Department of Biochemistry and Molecular Biophysics, Columbia University, New York, NY 10032, USA.\', \'BIOQUAL, Rockville, MD 20850, USA.\', \'Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA; Department of Surgery, Duke University, Durham, NC 27710, USA.\', \'Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA; Department of Immunology, Duke University School of Medicine, Durham, NC 27710, USA. Electronic address: barton.haynes@duke.edu.\', \'Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA; Department of Surgery, Duke University, Durham, NC 27710, USA; Department of Immunology, Duke University School of Medicine, Durham, NC 27710, USA; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710, USA. Electronic address: kevin.saunders@duke.edu.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0092-8674(21)00756-X10.1016/j.cell.2021.06.021
?:doi
?:hasPublicationType
?:journal
  • Cell
is ?:pmid of
?:pmid
?:pmid
  • 34242577
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 25.137
?:rankingScore_hIndex
  • 682
is ?:relation_isRelatedTo_publication of
?:title
  • In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all